Related Experiment Video
Updated: Sep 17, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.0K
Digitalization of Follow-up Program for Children with Type 1 Diabetes
Lilit Avetisyan1, Armine Lulejian2, Tsaghkanush Sargsyan3
1Ministry of Health, Yerevan, Armenia.
Studies in Health Technology and Informatics
|July 1, 2025
Summary
Digital registries improve data for pediatric type 1 diabetes (T1D) management. This study implements digital follow-up to reduce in-person visits for rural T1D patients.
Area of Science:
- Pediatric Endocrinology
- Digital Health
- Chronic Disease Management
Background:
- Digital registries are vital for collecting data on pediatric chronic diseases, particularly type 1 diabetes (T1D).
- Electronic platforms offer superior data quality and efficiency compared to paper-based systems.
- Type 1 diabetes requires lifelong insulin therapy and frequent endocrinologist follow-ups (every 3 months) as per clinical guidelines.
Purpose of the Study:
- To implement established guidelines for patient journey and digitalized follow-up of pediatric type 1 diabetic patients.
- To reduce the frequency of in-person follow-up visits, especially for rural pediatric patients.
- To leverage digital healthcare solutions for improved management of type 1 diabetes in children.
Main Methods:
- Utilizing digital registries to track and analyze data for pediatric patients with type 1 diabetes.
- Implementing a digitalized follow-up strategy based on current clinical guidelines.
- Focusing on a cohort of 890 children in Armenia, with 99.4% diagnosed with type 1 diabetes.
Main Results:
- The study focuses on implementing digitalized follow-up processes.
- The primary objective is to decrease the need for in-person visits for rural pediatric patients with T1D.
- Data analysis from digital registries will inform the effectiveness of the implemented strategy.
Conclusions:
- Digitalization of healthcare significantly impacts patient management, offering enhanced efficiency and data quality.
- Implementing digital follow-up protocols can optimize care delivery for pediatric type 1 diabetes.
- Reducing in-person visits through digital means can improve accessibility and adherence for rural populations.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes: Management and Pharmacotherapy
409
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
409
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Insulin: Dosing Regimen and Adverse Effects
268
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
268
Diabetes: Symptoms, Diagnosis, and Complications
706
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
706
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K

